Archives

by in
Entry Author Date Location
Nevro Obtains $48,000,000 Series C Funding Round 03/07/13 San Francisco
Genocea Biosciences Secures $30,000,000 Series C Financing 10/10/12 Boston
Cardiac Dimensions Nabs $5.8M for Heart Failure Device 09/12/12 Seattle
Astute Medical Receives $40,400,000 Series C Funding 06/07/12 San Diego
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Mitralign Lands $35,000,000 Series D Round 05/16/12 Boston
Celladon Garners $43,000,000 New Funding Round 02/16/12 San Diego
Clarimedix Receives New Financing Round 01/13/12 Boulder/Denver
GI Dynamics Raises $85M USD in Aussie IPO 08/30/11 Boston
Nevro Raises $58M for Anti-Pain Device 07/20/11 San Francisco
Nevro Lands $58,000,000 New Financing 07/20/11 San Francisco
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra 04/19/11 Boston
Astute Extends Series B Funding to $39.5M 03/09/11 San Diego
Astute Medical Obtains $13,000,000 Series B Funding 03/08/11 San Diego
23andMe Adds $9M to VC Round 01/07/11 San Francisco
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Genocea Biosciences Obtains $35,000,000 Series B Funding Round 01/03/11 Boston
Light Sciences Oncology CEO Exits for New Job; Company Still Waiting for Pivotal Results 11/22/10 Seattle
23andMe Raises $22M 11/09/10 San Francisco
23andMe Lands $22,000,000 Series C Financing Round 11/09/10 San Francisco
INTIO Garners $4,100,000 New Funding Round 10/14/10 Boulder/Denver
Aquinox Pharma Nabs $25M 06/17/10 Seattle
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
Breathe Technologies Garners $23,000,000 Series C Round 05/18/10 San Francisco
Astute Medical Garners $26,500,000 Series B Financing 05/11/10 San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
Light Sciences Oncology Sits Tight, Awaits Key Cancer Trial Results This Summer 03/01/10 Seattle
GI Dynamics Gets European Approval 12/22/09 Boston
Spinal Modulation Garners $27,400,000 Series C Funding 11/09/09 San Francisco
Page 1 of 2 next page »